Posted 3/12/2024, 4:15:00 PM
Oral Transmucosal Drug Market to Double in Size over Next Decade, Reaching $35 Billion by 2034
- Global oral transmucosal drugs market to more than double from $16.24 billion in 2023 to $35.65 billion in 2034, growing at a 7.41% CAGR
- Market growth driven by rising chronic diseases, advances in drug delivery technology, and innovations like dissolvable films and mucoadhesive gels
- Tablets segment currently leads market due to ease of use and patient familiarity
- Sublingual route generates substantial revenue due to rapid absorption from blood vessels under tongue
- North America dominates market now due to sophisticated healthcare, but Asia-Pacific to exhibit fastest growth propelled by healthcare infrastructure improvements